Description

Ethyl 7-(2,6-Dimethyl-4-Pyridyl)-1,4-Dihydro-4-Oxoquinoline-3-Carboxylate is a high-purity, advanced pharmaceutical intermediate of significant commercial interest. This compound serves as a critical building block in the synthesis of novel quinolone-based active pharmaceutical ingredients (APIs), valued for its precise molecular architecture. It is primarily sought by research institutions and manufacturers in the pharmaceutical and fine chemical sectors engaged in developing next-generation therapeutic agents.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel quinolone and fluoroquinolone antibiotic candidates.
• Medicinal Chemistry Research: Used in R&D for structure-activity relationship (SAR) studies and the development of new chemical entities targeting bacterial infections.
• API Synthesis: Employed in multi-step synthetic routes for the production of complex, high-value active pharmaceutical ingredients.
• Fine Chemical Production: Serves as a specialized building block for custom synthesis and contract manufacturing organizations (CMOs).
• Biochemical Research: Utilized in studies exploring enzyme inhibition and novel mechanisms of action for antimicrobial agents.

Basic Information

Product Name	Ethyl 7-(2,6-Dimethyl-4-Pyridyl)-1,4-Dihydro-4-Oxoquinoline-3-Carboxylate
CAS No.	40034-49-9
Molecular Formula	C19H18N2O3
Molecular Weight	322.36 g/mol
Synonyms	Ethyl 7-(2,6-Dimethylpyridin-4-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylate; 7-(2,6-Dimethyl-4-pyridinyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester; 3-Quinolinecarboxylic acid, 1,4-dihydro-7-(2,6-dimethyl-4-pyridinyl)-4-oxo-, ethyl ester; Ethyl 1,4-dihydro-7-(2,6-dimethyl-4-pyridyl)-4-oxoquinoline-3-carboxylate; 7-(2,6-Dimethyl-4-pyridyl)-1,4-dihydro-4-oxo-3-quinolinecarboxylic Acid Ethyl Ester; 40034-49-9; UNII-6V7R2Q5G8F
EINECS	Contact for details

Quality Control

Our Ethyl 7-(2,6-Dimethyl-4-Pyridyl)-1,4-Dihydro-4-Oxoquinoline-3-Carboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and synthesis. Certificates of Analysis (COA) with detailed specifications are available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (15-25°C). Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.